266 related articles for article (PubMed ID: 31695352)
21. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
[TBL] [Abstract][Full Text] [Related]
22. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
[TBL] [Abstract][Full Text] [Related]
23. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
[TBL] [Abstract][Full Text] [Related]
24. The association of elevated circulating endocan levels with lung function decline in COPD patients.
Dai L; He J; Chen J; Wang T; Liu L; Shen Y; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2018; 13():3699-3706. PubMed ID: 30519013
[TBL] [Abstract][Full Text] [Related]
25. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
26. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
[TBL] [Abstract][Full Text] [Related]
27. Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.
Calderazzo MA; Trujillo-Torralbo MB; Finney LJ; Singanayagam A; Bakhsoliani E; Padmanaban V; Kebadze T; Aniscenko J; Elkin SL; Johnston SL; Mallia P
Int J Chron Obstruct Pulmon Dis; 2019; 14():823-832. PubMed ID: 31114182
[No Abstract] [Full Text] [Related]
28. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
29. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
[TBL] [Abstract][Full Text] [Related]
31. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
32. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
33. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
34. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
36. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
38. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
[TBL] [Abstract][Full Text] [Related]
39. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
40. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
